JP2000236877A - 精度管理用物質 - Google Patents
精度管理用物質Info
- Publication number
- JP2000236877A JP2000236877A JP11093232A JP9323299A JP2000236877A JP 2000236877 A JP2000236877 A JP 2000236877A JP 11093232 A JP11093232 A JP 11093232A JP 9323299 A JP9323299 A JP 9323299A JP 2000236877 A JP2000236877 A JP 2000236877A
- Authority
- JP
- Japan
- Prior art keywords
- quality control
- substance
- prepared
- human
- serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000126 substance Substances 0.000 title claims abstract description 42
- 238000003908 quality control method Methods 0.000 title claims abstract description 22
- 230000006798 recombination Effects 0.000 claims abstract description 6
- 108091006905 Human Serum Albumin Proteins 0.000 claims abstract description 5
- 102000008100 Human Serum Albumin Human genes 0.000 claims abstract description 5
- 210000002966 serum Anatomy 0.000 claims description 15
- 102000004190 Enzymes Human genes 0.000 claims description 14
- 108090000790 Enzymes Proteins 0.000 claims description 14
- 102000004169 proteins and genes Human genes 0.000 claims description 14
- 108090000623 proteins and genes Proteins 0.000 claims description 14
- 241001465754 Metazoa Species 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 7
- 238000012239 gene modification Methods 0.000 claims 1
- 230000005017 genetic modification Effects 0.000 claims 1
- 235000013617 genetically modified food Nutrition 0.000 claims 1
- 239000012086 standard solution Substances 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 10
- 238000000034 method Methods 0.000 description 7
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 6
- 229940098773 bovine serum albumin Drugs 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 3
- 108010082126 Alanine transaminase Proteins 0.000 description 3
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 3
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 3
- 108010071390 Serum Albumin Proteins 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 108010074051 C-Reactive Protein Proteins 0.000 description 2
- 102100032752 C-reactive protein Human genes 0.000 description 2
- 102000003914 Cholinesterases Human genes 0.000 description 2
- 108090000322 Cholinesterases Proteins 0.000 description 2
- 102000004420 Creatine Kinase Human genes 0.000 description 2
- 108010042126 Creatine kinase Proteins 0.000 description 2
- 102000008857 Ferritin Human genes 0.000 description 2
- 108050000784 Ferritin Proteins 0.000 description 2
- 238000008416 Ferritin Methods 0.000 description 2
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 2
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 2
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 102000004338 Transferrin Human genes 0.000 description 2
- 108090000901 Transferrin Proteins 0.000 description 2
- -1 Tris buffer Chemical compound 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 239000003613 bile acid Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229940048961 cholinesterase Drugs 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000012581 transferrin Substances 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- FRPHFZCDPYBUAU-UHFFFAOYSA-N Bromocresolgreen Chemical compound CC1=C(Br)C(O)=C(Br)C=C1C1(C=2C(=C(Br)C(O)=C(Br)C=2)C)C2=CC=CC=C2S(=O)(=O)O1 FRPHFZCDPYBUAU-UHFFFAOYSA-N 0.000 description 1
- 101710134031 CCAAT/enhancer-binding protein beta Proteins 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 102000012406 Carcinoembryonic Antigen Human genes 0.000 description 1
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 1
- 102100023441 Centromere protein J Human genes 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 101710199286 Cytosol aminopeptidase Proteins 0.000 description 1
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
- 101710197780 E3 ubiquitin-protein ligase LAP Proteins 0.000 description 1
- 101710107035 Gamma-glutamyltranspeptidase Proteins 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101710173228 Glutathione hydrolase proenzyme Proteins 0.000 description 1
- 108010022203 Leucine transaminase Proteins 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- 101710204480 Lysosomal acid phosphatase Proteins 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 101710089118 Probable cytosol aminopeptidase Proteins 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 229960005156 digoxin Drugs 0.000 description 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11093232A JP2000236877A (ja) | 1999-02-23 | 1999-02-23 | 精度管理用物質 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11093232A JP2000236877A (ja) | 1999-02-23 | 1999-02-23 | 精度管理用物質 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000236877A true JP2000236877A (ja) | 2000-09-05 |
| JP2000236877A5 JP2000236877A5 (https=) | 2006-03-09 |
Family
ID=14076805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11093232A Pending JP2000236877A (ja) | 1999-02-23 | 1999-02-23 | 精度管理用物質 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2000236877A (https=) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002052278A1 (en) * | 2000-12-22 | 2002-07-04 | International Reagents Corporation | Clinical examination precision guarantee system |
| WO2003066681A1 (en) * | 2002-02-05 | 2003-08-14 | Delta Biotechnology Limited | Stabilization of protein preparations |
| JP2007271641A (ja) * | 2007-07-26 | 2007-10-18 | Sysmex Corp | 精度管理方法 |
| JP2007279059A (ja) * | 2007-06-18 | 2007-10-25 | Sysmex Corp | 臨床検査精度管理システム |
| JP2007286071A (ja) * | 2007-07-26 | 2007-11-01 | Sysmex Corp | 精度管理方法 |
| JP2009020126A (ja) * | 2008-10-28 | 2009-01-29 | Sysmex Corp | 精度管理方法 |
| JP2012532312A (ja) * | 2009-06-30 | 2012-12-13 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 磁気センサ装置、このような装置の作動方法及びサンプル |
| CN101809161B (zh) * | 2007-08-07 | 2014-03-12 | 中外制药株式会社 | 异种蛋白的制备方法 |
| CN113049839A (zh) * | 2019-12-27 | 2021-06-29 | 桂林英美特生物技术研究所 | 一种稳定的肝功能类复合质控品 |
-
1999
- 1999-02-23 JP JP11093232A patent/JP2000236877A/ja active Pending
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002052278A1 (en) * | 2000-12-22 | 2002-07-04 | International Reagents Corporation | Clinical examination precision guarantee system |
| WO2003066681A1 (en) * | 2002-02-05 | 2003-08-14 | Delta Biotechnology Limited | Stabilization of protein preparations |
| JP2007279059A (ja) * | 2007-06-18 | 2007-10-25 | Sysmex Corp | 臨床検査精度管理システム |
| JP2007271641A (ja) * | 2007-07-26 | 2007-10-18 | Sysmex Corp | 精度管理方法 |
| JP2007286071A (ja) * | 2007-07-26 | 2007-11-01 | Sysmex Corp | 精度管理方法 |
| CN101809161B (zh) * | 2007-08-07 | 2014-03-12 | 中外制药株式会社 | 异种蛋白的制备方法 |
| JP2009020126A (ja) * | 2008-10-28 | 2009-01-29 | Sysmex Corp | 精度管理方法 |
| JP2012532312A (ja) * | 2009-06-30 | 2012-12-13 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 磁気センサ装置、このような装置の作動方法及びサンプル |
| US9557328B2 (en) | 2009-06-30 | 2017-01-31 | Koninklijke Philips N.V. | Magnetic sensor device, method of operating such a device and sample |
| CN113049839A (zh) * | 2019-12-27 | 2021-06-29 | 桂林英美特生物技术研究所 | 一种稳定的肝功能类复合质控品 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Eggermont et al. | Ca2+-transport ATPases of vascular smooth muscle. | |
| US5583200A (en) | Stabilized composition of troponin for immunoassays and process for stabilizing troponin for immunoassays | |
| JP5816376B2 (ja) | 分析アッセイのためのカスタマイズされた品質対照 | |
| JP2008544977A (ja) | タンパク質を含む安定水系 | |
| JP2000236877A (ja) | 精度管理用物質 | |
| JP4106111B2 (ja) | イムノアッセイ用較正／対照用配合物 | |
| CN111060692A (zh) | 一种免疫球蛋白g1的检测试剂盒及其制备方法 | |
| JPH0222909B2 (https=) | ||
| Perrin et al. | Competitive binding of two drugs for a single binding site on albumin: a circular dichroic study | |
| US20040033529A1 (en) | Stabilized composition of troponin for immunoassays and method of preparation of such a stabilized composition | |
| JPS6176423A (ja) | モノクロナ−ル抗体の安定化 | |
| JP4261665B2 (ja) | 溶液中のヒトヘモグロビンの安定化方法および安定化溶液 | |
| US20030125234A1 (en) | Alteration of protein stability | |
| JPH10282105A (ja) | 血清アミロイドａ測定用キャリブレーターの製造方法 | |
| JP4033534B2 (ja) | ヒトヘモグロビンの安定化方法 | |
| JP4546596B2 (ja) | ステロールエステルの添加による生物学的液体の安定化 | |
| WO2006054519A1 (ja) | リポ蛋白中成分の分別定量用標準品 | |
| WO2011058958A1 (ja) | ヘムタンパク質の安定化用組成物及びそれを用いたヘムタンパク質の安定化方法 | |
| JP2542787B2 (ja) | チロキシン（ｔ４）またはトリヨ−ドチロニン（ｔ３）の測定法およびそのための標準溶液 | |
| JP3872880B2 (ja) | 感作金属コロイド含有安定化凍結乾燥物及びその製造方法 | |
| TW201609191A (zh) | 血清或血漿中高密度脂蛋白之安定劑及安定化方法 | |
| JP4273534B2 (ja) | ヘム蛋白質の安定化剤及び安定化方法 | |
| JP2000131323A (ja) | 調整管理血清 | |
| JP3348573B2 (ja) | ヒトヘモグロビンの安定化試薬及び安定化方法 | |
| JP2007212343A (ja) | 抗原の測定法およびそれに用いるキット |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20050928 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060123 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060123 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20071102 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20081029 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081201 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090128 |